Cognetivity Neurosciences Ltd. CGNSF
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.0019 Day range 0.0019
0.0001 52-week range 0.0019
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 8.96K
- EPS (ttm)
- -0.06
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 1.00K
- Open
- 0.0019
- Previous close
- 0.0001
- Day's range
- 0.0019 – 0.0019
- 52-week range
- 0.0001 – 0.0019
6M 0.0000 (0.00%)
News
CSE Bulletin: Delist - Cognetivity Neurosciences Ltd. (CGN) 
CognICA(TM) Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service 
Cognetivity Neurosciences and UC Health Partner to Improve Early Detection of Cognitive Impairment in USA 
Cognetivity Neurosciences Announces Commercial Agreement with Mediclinic to Provide Cognitive Assessment to Over 50s 
Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology 
Cognetivity Neurosciences' AI Powered CognICA Platform Wins Major Industry Award 
Cognetivity Neurosciences' AI Powered CognICA Platform Shortlisted for Major Industry Award 
Cognetivity Neurosciences Announces Publication of Peer-Reviewed Article Showing Effectiveness of its AI Powered CognICA Technology in Detecting Early-Stage Alzheimer's Disease 
Cognetivity Neurosciences Announces Successful Registration With Health Canada for Clinical use of CognICA(TM) AI-Powered Brain Health Technology in Canada 
New Disease Modifying Drug for Alzheimer's Disease Fully Approved by FDA, Highlighting the Crucial Role for Cognetivity in Early Detection and Monitoring
Your note
Sign in to keep a note on CGNSF — it syncs with the Stock Master app.